Based in Chicago, Illinois, Ventas, Inc. (VTR) is a healthcare real estate investment trust (REIT) engaged in the acquisition, ownership, and leasing of senior housing, life science, research & innovation (R&I), and healthcare properties. Valued at a market cap of $26.1 billion, the company offers MOB management, leasing, marketing, facility development, and advisory services to hospitals & health systems.
Companies worth more than $10 billion are generally described as “large-cap” stocks, and Ventas fit right into that category. The company has a portfolio of approximately 1,350 properties. It is renowned for its seasoned team of talented professionals who share a commitment to excellence, integrity, and a common purpose of helping people live longer, healthier, happier lives.
Shares of VTR are trading 1.8% below their 52-week high of $65.64, which they hit on Sep. 13. VTR has gained 28.2% over the past three months, surpassing the broader S&P 500 Index’s ($SPX) 2.7% returns over the same time frame.
In the longer term, VTR stock is up 29.3% on a YTD basis, surpassing SPX’s 18.1% gains. Moreover, shares of VTR have gained 47.5% over the past 52 weeks, outperforming SPX’s 26.5% returns over the same time frame.
To confirm its bullish trend, VTR has been trading above its 200-day moving average since early May and has remained above its 50-day moving average since late April.
Shares of VTR gained 2% following its Q2 earnings release on Aug. 1. The company reported an FFO of $0.80 per share, which surpassed Wall Street estimates of $0.79. It also surpassed the revenue forecasts, posting $1.2 billion compared to the expected $1.19 billion. Ventas raised the full-year FFO outlook to $3.12 - $3.18 per share, further boosting investor confidence.
However, VTR has lagged behind its rival, Welltower Inc. (WELL), which gained 50.8% over the past 52 weeks and 41.8% on a YTD basis.
Given that VTR outperformed the broader market, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 19 analysts in coverage, and as of writing, the company is trading above its mean price target of $63.
More Stock Market News from Barchart
- How Is Tyler Technologies’ Stock Performance Compared to Other Software Stocks?
- 3 Asset Managers Hitting 52-Week Highs to Buy for the Long Haul
- Intuitive Machines, the Satellite Company, Rockets 50%+, Spurring Unusual Options Activity
- 1 Analyst Says This AI Stock Will Overshadow Nvidia
